Brightsurf Science News & Current Events

May 18, 2002
Insurers should pay for children's costly cancer treatments
Insurance companies typically should pay for expensive cancer therapies in children because the vast majority of treatments extend children's lives for 30 to 50 years, more than justifying the high initial cost, says a Duke Comprehensive Cancer Center researcher.

New drug regimen shows clear benefit for treating advanced colorectal cancer
Initial results from a large, randomized clinical trial for patients with advanced colorectal cancer show that those who received a regimen containing the investigational drug oxaliplatin lived months longer than those who received a standard therapy.

Radiation alone after surgery still the standard for head and neck cancer
A preliminary study has found no advantage to adding chemotherapy to radiation after surgery for treating advanced head and neck cancer patients.

New breast cancer therapy trials show dramatic results
Patients of Kimberly Blackwell, M.D., jokingly call their treatment table the is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to